Eating the Dead to Keep Atherosclerosis at Bay

Area of Science:

• Cardiovascular Science
• Cell Biology
• Pathology

Background:

• Atherosclerosis is a primary cause of mortality globally, with increasing prevalence in developing nations.
• Despite effective treatments, it remains a leading cause of death, driven by arterial hardening and high cholesterol.
• Current therapies do not adequately address critical processes like cell death and efferocytosis within atherosclerotic plaques.

Purpose of the Study:

• To review the mechanisms linking endoplasmic reticulum stress and cholesterol metabolism to cell death and inflammation in atherosclerosis.
• To examine the impact of dying cells on atherosclerotic plaque progression and regression.
• To explore how autophagy and efferocytosis influence the plaque's inflammatory environment and potential therapeutic strategies.

Main Methods:

• Literature review of studies on cell death, endoplasmic reticulum stress, cholesterol metabolism, and efferocytosis in atherosclerosis.
• Analysis of research on the role of autophagy in clearing apoptotic cells within plaques.
• Synthesis of current therapeutic approaches targeting these cellular processes.

Main Results:

• Endoplasmic reticulum stress and dysregulated cholesterol metabolism are key drivers of cell death and inflammation.
• Dying cells significantly influence atherosclerotic plaque progression and regression dynamics.
• Autophagy and efficient efferocytosis can ameliorate the inflammatory milieu of atherosclerotic plaques.

Conclusions:

• Understanding cell death and clearance mechanisms is crucial for developing novel cardiovascular disease therapies.
• Targeting endoplasmic reticulum stress, cholesterol metabolism, and efferocytosis offers promising therapeutic avenues.
• Developing therapeutics that specifically target atherosclerotic plaques holds potential for improved treatment outcomes.